1Senior Resident, Department of General Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana 124001, India. 2PG Trainee, SGT Medical College, Gurugram, Haryana 122505, India.
Choose an option to locate / access this Article:
90 days Access
Check if you have access
through your login credentials.
PDF
Dipeptidyl peptidase IV (DPP-IV) inhibitors such as sitagliptin prolong the duration of active incretin hormones such as glucagon-like peptide 1 (GLP-1) in the bloodstream and thereby enhances control of type 2 diabetes. Adverse events with sitagliptin include upper respiratory tract infections, sore throat, headache and diarrhea. It has also been linked with pan creatitis in case reports, animal studies and postmarketing drug surveillance studies. We report a case of 52 year old diabetic female taking sitagliptin since 2 months presented with abdominal pain and vomiting since 2 days and was diagnosed as acute pancreatitis.
Keywords : Type II Diabetes Mellitus; Sitagliptin; Dipeptidyl Peptidase Iv Inhibitor; Acute Pancreatitis.
Corresponding Author : Archit Dahiya, Senior Resident, Department of General Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana 124001, India.
Author Information Pack
Editorial Board 
Submit article
Editor's selection process
Most popular articles
Archive
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us